Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper.

Human plasma low-density lipoproteins (LDL) were incubated with 10 microM probucol for 1 h at 37 degrees C. Probucol incorporation into the LDL was complete as judged by filtration through a 0.2-micron filter, ultracentrifugation, and gel filtration. LDL with and without probucol were incubated for up to 24 h with 5 microM Cu2+ at 37 degrees C. Copper oxidation increased the content of random structure in the LDL protein from 30% to 36% at the expense of beta-structure (which decreased from 22% to 16%) without a change in alpha-helical content as measured by circular dichroism spectroscopy. This loss of beta-structure was prevented by the presence of probucol in the LDL during the copper incubation. Probucol reduced the rate of increase of fluorescence during copper oxidation at 37 degrees C. After 6 h, the fluorescence intensity at 360-nm excitation and 430-nm emission was 30% less in probucol-containing samples. Probucol had no effect on the circular dichroic spectrum of LDL and only minimal effects (less than 5%) on the fluorescence emission spectrum at wavelengths below 500 nm. Two fluorescence peaks, with emission at 420 nm and excitation at 340 and 360 nm, are resolved in three-dimensional fluorescence spectra of oxidized LDL. Probucol reduces the intensity of both peaks equally. The binding of a highly reactive heparin (HRH) fraction to LDL was measured by titration of LDL with HRH in the presence of fluoresceinamine-labeled HRH. The decrease in fluorescence anisotropy of the labeled HRH is proportional to the concentration of bound HRH.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  L. McLean,et al.  Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine. , 1988, Biochimica et biophysica acta.

[2]  S. Parthasarathy,et al.  Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. , 1987, Journal of lipid research.

[3]  D. Chapman,et al.  Changes in the secondary structure of apolipoprotein B-100 after Cu2+-catalysed oxidation of human low-density lipoproteins monitored by Fourier transform infrared spectroscopy. , 1987, Biochimica et biophysica acta.

[4]  G. Chisolm,et al.  Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. , 1987, Chemistry and physics of lipids.

[5]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Jackson,et al.  Physical-chemical interaction of heparin and human plasma low-density lipoproteins. , 1987, Biochemistry.

[7]  R. Jackson,et al.  Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B. , 1987, Biochemistry.

[8]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  O. Quehenberger,et al.  Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. , 1987, Journal of lipid research.

[10]  U. Steinbrecher,et al.  Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. , 1987, The Journal of biological chemistry.

[11]  B. Wallace,et al.  Differential absorption flattening optical effects are significant in the circular dichroism spectra of large membrane fragments. , 1987, Biochemistry.

[12]  W. Li,et al.  The complete cDNA and amino acid sequence of human apolipoprotein B-100. , 1986, The Journal of biological chemistry.

[13]  R. Jackson,et al.  Interaction of tryptic peptides of apolipoprotein B-100 with dimyristoylphosphatidylcholine. , 1986, Biochimica et biophysica acta.

[14]  T. Funahashi,et al.  Effects of probucol on xanthomata regression in familial hypercholesterolemia. , 1986, The American journal of cardiology.

[15]  J. Huttunen,et al.  Long-term use of probucol in the multifactorial primary prevention of vascular disease. , 1986, The American journal of cardiology.

[16]  L. McLean,et al.  Interaction of lipoprotein lipase with phospholipid vesicles: effect on protein and lipid structure. , 1986, Biochemistry.

[17]  S. Young,et al.  Probucol inhibits oxidative modification of low density lipoprotein. , 1986, The Journal of clinical investigation.

[18]  H. Esterbauer,et al.  Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. , 1986, Biochimica et biophysica acta.

[19]  J T Yang,et al.  Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.

[20]  L. McLean,et al.  Interaction of lipoprotein lipase and apolipoprotein C-II with sonicated vesicles of 1,2-ditetradecylphosphatidylcholine: comparison of binding constants. , 1985, Biochemistry.

[21]  A. Chait,et al.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. , 1984, The Journal of clinical investigation.

[22]  T. Carew,et al.  A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. , 1984, Journal of lipid research.

[23]  S. Grundy,et al.  Influence of probucol on cholesterol and lipoprotein metabolism in man. , 1984, Journal of lipid research.

[24]  D. Morel,et al.  Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation , 1984, Arteriosclerosis.

[25]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[27]  D. Steinberg,et al.  Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.

[28]  R. Jackson,et al.  Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B. , 1982, Biochemistry.

[29]  B. Joffe,et al.  Treatment of homozygous familial hypercholesterolaemia with probucol. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[30]  P. Edwards,et al.  Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Simons,et al.  On the mechanism of plasma cholesterol reduction in the rat given probucol. , 1981, Clinical science.

[32]  D. Steinberg,et al.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Shio,et al.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[35]  R H Haschemeyer,et al.  Oxygen-mediated heterogeneity of apo-low-density lipoprotein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. W. Barnhart,et al.  Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol). , 1970, The American journal of clinical nutrition.

[37]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[38]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.